Does the use of immunohistochemistry to identify micrometastases provide useful information in the staging of node-negative non-small cell lung carcinomas?

Lung Cancer

Volumn 18, Issue 3, 1997, Pages 231-240

  Nicholson, A G ^a   Graham, A N J ^a   Pezzella, F ^b   Agneta, G ^a   Goldstraw, P ^a   Pastorino, U ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Carcinoma; Immunohistochemistry; Lung; Mesothelial inclusion; Micrometastasis; Minimal residual disease

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE; MESOTHELIUM CELL; METASTASIS; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; STAGING;

ANTIBODIES; CARCINOMA, NON-SMALL-CELL LUNG; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STAINING AND LABELING;

EID: 0030775211     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(97)00065-2     Document Type: Article

References (28)

1. Anderson TJ Occult axillary lymph-node micrometastases in breast cancer. Lancet. 336:1990;435.
2. Ballantyne AJ, Clagett OT, McDonald JR Vascular invasion in bronchogenic carcinoma. Thorax. 12:1957;294-299.
3. Brooks JSJ, LiVolsvi VA, Pietra GG Mesothelial cell inclusions in mediastinal lymph nodes mimicking metastatic carcinoma. Am J Clin Pathol. 93:1990;741.
4. Buhr J, Berghauser KH, Morr H, Dorrbroschke J, Ebner HJ Tumor cells in intraoperative pleural lavage. Cancer. 65:1990;1801-1804.
5. Chen Z, Perez S, Carmack Holmes E, Wang H, Coulson WF, Cochran AJ Frequency and distribution of occult metastases in lymph nodes of patients with non-small-cell carcinoma. J Natl Cancer Inst. 85(6):1993;493-497.
6. Clement PB, Young RH, Oliva E, Sumner HW, Scully RE Hyperplastic mesothelial cells within abdominal lymph nodes: mimic of metastatic ovarian carcinoma and serous borderline tumour - a report of two cases associated with ovarian neoplasms. Mod Pathol. 9:1996;879-886.
7. Colby, TV, Koss, MN, Travis, WD. Carcinoma of the lung: clinical and radiographic aspects, spread, staging, management, and prognosis. In: Rosai, J, editor. Atlas of tumor pathology: tumors of the respiratory tract. Third series, Fascicle 13. Washington, D.C. Armed Forces Institute of Pathology, 1995;107-134.
8. Collier FC, Enterline HT, Kyle RH, Tristan TT, Greening R The prognostic implications of vascular invasion in primary carcinomas of the lung. Arch Pathol. 66:1958;593-603.
9. Cote RJ, Beattie EJ, Chaiwun B Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg. 222:1995;415-425.
10. Galea MH, Ellis IO, Elston CW, Blamey RW Occult axillary lymph node metastases in breast cancer. Lancet. 336:1990;435.
11. Ghossein RA, Rosai J Polymerase chain reaction in the detection of micrometastases and circulating tumour cells. Cancer. 78:1996;10-16.
12. Gusterson BA, Ott R Occult axillary lymph-node micrometastases in breast cancer. Lancet. 336:1990;434.
13. International (Ludwig) Breast Cancer Study Group Prognostic importance of occult axillary lymph node metastases from breast cancers. Lancet. 335:1990;1565-1568.
14. Izbicki JR, Passlick B, Hosch SBet al. Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis. J Thorac Cardiovasc Surg. 112:1996;623-630.
15. Kolin K, Koutoulakis T Invasion of pulmonary arteries by bronchial carcinomas. Hum Pathol. 18:1987;1165-1171.
16. Kondo H, Asamura H, Suemasa KR Prognostic significance of pleural lavage cytology immediately after thoracotomy in patients with lung cancer. J Thorac Cardiovasc Surg. 106:1993;1092-1097.
17. Margolis ML, Desai B, Racely E, Schepart BS Frequency and clinical implications of monoclonal antibody detection of tumour-associated antigens in serum of patients with lung cancer. Am Rev Respir Dis. 142:1990;1059-1062.
18. Mountain CF The new international system for staging lung cancer. Chest. 89:1986;225S-33S.
19. Mountain CF Value of the new TNM staging for lung cancer. Chest. 96:1989;47S-49S.
20. Naruke T, Suemasu K, Ishikawa S Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg. 76:1978;832.
21. Okumura M, Ohshima S, Kotake Y, Morino H, Kikui M, Yasumitsu T Intrapoperative pleural lavage cytology in lung cancer patients. Ann Thorac Surg. 51:1991;599-604.
22. Passlick B, Izbicki JR, Kubuschak Bet al. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol. 12(9):1994;1827-1832.
23. Passlick B, Izbicki JR, Kubuschok B, Thetter O, Pantel K Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg. 61:1996;177-183.
24. Rutty GN, Lauder I Mesothelial cell inclusions within mediastinal lymph nodes. Histopathology. 25:1994;483.
25. Saphir O, Amromin GD Obscure axillary lymph node micrometastases in breast cancer. Cancer. 1:1948;238-241.
26. Smit EF, Groen HJM, Splinter TAW, Ebels T, Postmus PE New prognostic factors in resectable non-small cell lung cancer. Thorax. 51:1996;638-646.
27. Stewart THM Immune mechanisms and tumor dormancy. Medicina-Buenos Aires. 56:1996;74-82.
28. Wilkinson EJ, Hause L Probability in lymph node sectioning. Cancer. 33:1974;1269-1274.